International Review of Ophthalmology

Previous Articles     Next Articles

Treatment of macular edema after vitrectomy

Wang Beibei, Li Qiuming, Dong Shuqian, Hu Zhirou   

  1. Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Henan Provincial Ophthalmic Hospital, Zhengzhou 450052, China
  • Received:2019-06-13 Online:2019-12-22 Published:2019-12-26
  • Contact: Li Qiuming, Email: liqiuming63@163.com
  • Supported by:

    National Natural Science Foundation of China (81800830)

Abstract:

The occurrence of macular edema (ME) after pars plana vitrectomy (PPV) severely affects postoperative visual acuity. Corticosteroids can effectively control the inflammatory response. It is currently the main method for the treatment of inflammation\|related ME after PPV. It can be applied topically, peri\|injection, or intravitreal injection of long\|acting or short\|acting glucocorticoids. Other treatments include surgical removal of macular membrane\|like traction, vitreous injection of anti\|vascular endothelial growth factor(VEGF), topical application of non\|steroidal anti\|inflammatory drugs, oral carbonic anhydrase inhibitors, subcutaneous injection of alpha-2a interferon and topical betalol.(Int Rev Ophthalmol, 2019, 43: 366-372)